2022
DOI: 10.1089/nat.2022.0024
|View full text |Cite
|
Sign up to set email alerts
|

Nucleic Acid Aptamers Increase the Anticancer Efficiency and Reduce the Toxicity of Cisplatin-Arabinogalactan Conjugates In Vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 38 publications
0
4
0
Order By: Relevance
“…A thiolated DNA aptamer (AS42) to EAC cells [27] capable of in vivo binding [28] and an oligonucleotide non-specific to EAC cells were used for the MND functionalization. The spatial structure of AS42 was described earlier [29]. MND functionalization (Figure 2) was performed according to the procedure described earlier in [26].…”
Section: Mnds and Their Functionalization With The Aptamersmentioning
confidence: 99%
“…A thiolated DNA aptamer (AS42) to EAC cells [27] capable of in vivo binding [28] and an oligonucleotide non-specific to EAC cells were used for the MND functionalization. The spatial structure of AS42 was described earlier [29]. MND functionalization (Figure 2) was performed according to the procedure described earlier in [26].…”
Section: Mnds and Their Functionalization With The Aptamersmentioning
confidence: 99%
“…Cis-AG-Ap also successfully suppressed Ehrlich’s ascites carcinoma growth and the extent of tumor metastasis in vivo. The use of arabinogalactan and aptamers improved the bioavailability and efficiency of cisplatin, making this strategy very promising for targeted cancer therapy [ 62 ].…”
Section: Overview On Polysaccharide-based Drug Delivery Systemsmentioning
confidence: 99%
“…Cisplatin [62] Drug delivery systems with hepatocyte asialoglycoprotein receptor binding targeting the liver for in vivo antitumor efficacy. Self-assembled particles.…”
Section: Polysaccharide-based Drug Delivery Systems Classificationmentioning
confidence: 99%
“…Another example of ApDC was developed by conjugating aptamer AS-42 specific to heat-shock proteins Hspa8 and Hsp90ab1 with Cis-dichlorodiammineplatinum and Siberian larch arabinogalactan. This cisplatin-arabinogalactan-aptamer demonstrated a cytotoxicity effect against Ehrlich’s carcinoma [ 73 ]. Similarly, aptamer-siRNA chimeras injected intratumorally effectively targeted prostate-specific membrane antigens (PSMA) in vivo [ 74 ].…”
Section: Applications Of Aptamersmentioning
confidence: 99%